Senate hearing urges tighter protections for reproductive and gender‑affirming care under 2022 ‘shield law’

At a public hearing, the Massachusetts Senate Committee on Steering and Policy heard detailed testimony urging lawmakers to tighten and clarify the 2022 “shield law” that protects reproductive and gender‑affirming health care in the Commonwealth.

The hearing drew testimony from the attorney general’s office, civil‑liberties groups, medical societies, provider organizations and advocacy groups, all of whom recommended targeted changes: extend noncooperation rules to all state and local agencies, give the attorney general explicit enforcement authority, segregate sensitive data in electronic medical records, exclude certain medications from the state prescription monitoring program and allow dispensing providers to appear on prescription labels as a practice name rather than an individual clinician.

The protections matter because, speakers said, hostile federal actors and out‑of‑state officials are increasingly using civil and criminal tools to pursue providers and patients. “We cannot and should not wait to see how that reconciliation bill fares in the US Senate,” Senate Chair Cindy Friedman said in opening remarks, pointing to recent federal and out‑of‑state actions that advocates say have increased risks for providers and patients.

Allison Slater, director of Attorney General Andrea Campbell’s Reproductive Justice Unit, told the committee that Massachusetts’ shield law was “nation leading” when passed in 2022 but that developments since then exposed gaps. Slater recommended several statutory changes, including extending the law’s bar on…